MSDS   : Albumin, human serum sonicated
CAS   : 68814-95-9 SYNONYMS   : * S-132
* Sonicated human serum albumin
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : AY9386500
CHEMICAL NAME : Albumin, human serum sonicated
LAST UPDATED : 199306
DATA ITEMS CITED : 1
SYNONYMS/TRADE NAMES :
* S-132
* Sonicated human serum albumin
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >3 mL/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 41,481,1991
*** END OF RECORD ***
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAME CAS
Amine curing agent, CD 16005
597-40-0
Amine curing agent, CD 16009
597-40-0
Amine curing agent, CD 16018 A
597-40-0
Amine curing agent, CD 16019 A
597-40-0
Amine curing agent, XH 713-50
597-40-0
Amines, C(sub 18-20)-tert-alkyl
69225-84-9
Amines, C10-18-alkyl, hydrochlorides
80448-80-2
Albumin, egg
9006-59-1
Amines, N-C12-18-alkyltrimethylenedi-
68155-37-3
Amines, coco alkyl, benzoates
68526-65-8
Amines, N-coco alkyltrimethylenedi-
61791-63-7
Amines, N-coco alkyltrimethylenedi-, acetates
61791-64-8
Amines, N-coco alkyltrimethylenedi-, adipates
68155-42-0
Amines, N-coco alkyltrimethylenedi-, benzoates
68188-29-4
Amines, N-coco alkyltrimethylenedi-, glycolates
68155-43-1
Amines, hydrogenated tallow alkyl, acetates
61790-59-8
Amines, N-soya alkyltrimethylenedi-
61791-67-1
Amines, tallow alkyl, acetates
61790-60-1
Albumin, from grape seed
61790-60-1
Amines, N-tallow alkyltrimethylenedi-, diacetates
68911-78-4
Amines, tri-C(sub 8-10)-alkyl-
68814-95-9
Amino acid granule for heptic encephalopathy, MHS-G
68814-95-9
Amino acids, BCAA-GSUBSTANCE DEFINITION :Consists of 3 branched amino acids, L-isoleucine, L-leucine and L-valineREFERENCE :KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, KandaSuda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-Volume(issue)/page/year: 23,1843,1989
68814-95-9
Amino acid solution, ED-AC
68814-95-9
Amino acid solution for patients with hepaticencephalopathy, MHS-2
68814-95-9
Amino acid solution for renal failure, MRX-III
68814-95-9
Amino acid for renal insufficinecy, AMI-U-II
68814-95-9
Amino acid solution for renal insufficiency, TO-70
68814-95-9
Amino acid solution, Ispol
68814-95-9
Albumin, human serum sonicated
68814-95-9
Amino acid solution, Moriamin
68814-95-9
Amino acid solution, Moriamin-S
68814-95-9
Amino acids solution, MPR-F
65072-01-7
Amino acids solution, P-1
65072-01-7
Amino acid solution, TA 7.2
65072-01-7
Amino acid solution, TAT-7180H
65072-01-7
Amino acid solution, TAT-7180L
65072-01-7
Amino acids solution, CNT(H)
65072-01-7
Amino acids solution, CNT(L)
65072-01-7
Amino acids solution, CSH
65072-01-7
Albumin, pyrolyzate
65072-01-7
Amino acids solution, GA-1080(H)
65072-01-7
Amino acids solution, GM-1
65072-01-7
Amino acids solution, GM-2
65072-01-7
Amino acids solution, TAB-1
65072-01-7
Amino acids solution, TAB-2
65072-01-7
Aminoacylase
9012-37-7
alpha-Aminoimidazole-4-propionic acid, cobalt(2+)salt
14873-10-0
Amipramine, hydrochloride
14873-10-0
Amipurimycin, hydrateSUBSTANCE DEFINITION :Isolated from culture filtrate of Streptomyces novoguineesis T-36496REFERENCE :JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
14873-10-0